Movinavir 200mg Mekophar treated Covid-19 mild to medium level (10 blisters x 10 tablets)

Dosage form Box of 10 blisters x 10 tablets
Specifications Molnupiravir

Ingredient

Composition information	Content
Molnupiravir	200mg

Uses

Indications

Movinavir 200mg Mekophar is recommended to use the treatment of Covid-19 treatment to medium to medium level in adults positive for Covid-19 and at least one risk factor for severe disease progression when prescribed by a doctor or medical staff.

Pharmacological

No data.

pharmacokinetics

No data.

Before taking Movinavir 200mg Mekophar treated Covid-19 mild to medium level (10 blisters x 10 tablets)

How to use

oral medication.

Patients should take the whole pill with enough water (for example: 1 cup of water). Recommendation not to open, grind or chew tablets.

Dosage

Adults

Dosage recommended: Taking oral dose of 800 mg molnupiravir every 12 hours in 5 days.

Safety and effectiveness of molnupiravir when used for more than 5 days has not been determined.

Patients with Covid-19 should take molnupiravir as soon as possible after being diagnosed with viral infection and within 5 days from the beginning of symptoms.

Shelf limit:

Do not use molnupiravir for more than 5 consecutive days. Due to the lack of the benefits of molnupiravir when starting to use in this patient object. Patients who were used before hospitalization could continue to use drugs for sufficient treatment.

Children

Safety and effectiveness of molnupiravir in patients under the age of 18 have not been determined.

There is no data on children's patients. Recommendation should not be used for children.

Other objects

Elderly: No need to adjust the molnupiravir dose in elderly patients.

People with renal failure: No need to adjust the molnupiravir dose in patients with renal failure.

People with liver failure: No need to adjust the molnupiravir dose in patients with liver failure.

Specific dose depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

do when using overdose? If an overdose is used, it is necessary to handle it by general support measures, including monitoring the patient's clinical status. Hematoparoa is not effective in eliminating NHC (N-Hydroxycytidin).

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when forgetting a dose?

If you forget a dose of 10 hours, patients should not take the forgotten dose but need to take the next dose of the schedule. Do not use double the dose to compensate for the forgotten dose.

Side Effects

Notify the physician the unwanted effects when using the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Movinavir 200mg Mekophar contraindicated in the following cases:

Patients with hypersensitivity to the active ingredient molnupiravir.

Be cautious when using

According to the Molnupiravir Active Drug Administration, it is not recommended in the following cases:

It is not recommended for women during pregnancy.

Drug interaction

drug interactions may affect the activity of the drug or cause side effects.

Patients should notify the doctor or pharmacist a list of the drugs and functional foods you are using. Do not use or increase or decrease the dose of the drug without the guidance of a doctor.

Storage

Leave a cool place, avoid light, temperature below 30⁰C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.